Low-affinity major histocompatibility complex-binding peptides in type 1 diabetes.
作者信息
James Eddie A, Kwok William W
机构信息
Benaroya Research Institute, Virginia Mason Medical Center,Seattle, Washington, USA.
出版信息
Diabetes. 2008 Jul;57(7):1788-9. doi: 10.2337/db08-0530.
Abstract
摘要
相似文献
1
Low-affinity major histocompatibility complex-binding peptides in type 1 diabetes.
Diabetes. 2008 Jul;57(7):1788-9. doi: 10.2337/db08-0530.
2
Weak proinsulin peptide-major histocompatibility complexes are targeted in autoimmune diabetes in mice.
Diabetes. 2008 Jul;57(7):1852-60. doi: 10.2337/db08-0068. Epub 2008 Apr 8.
3
A TCR-like antibody against a proinsulin-containing fusion peptide ameliorates type 1 diabetes in NOD mice.
Biochem Biophys Res Commun. 2021 Jan 1;534:680-686. doi: 10.1016/j.bbrc.2020.11.019. Epub 2020 Nov 15.
4
A new look at MHC and autoimmune disease.
Science. 1999 Apr 30;284(5415):749, 751. doi: 10.1126/science.284.5415.749.
5
Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes.
J Immunol. 2001 Nov 1;167(9):4926-35. doi: 10.4049/jimmunol.167.9.4926.
6
Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II molecules.
Diabetologia. 2003 Apr;46(4):496-503. doi: 10.1007/s00125-003-1070-3. Epub 2003 Apr 9.
7
T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
J Autoimmun. 2004 Mar;22(2):121-9. doi: 10.1016/j.jaut.2003.10.003.
8
Understanding the interaction of genetics and cellular responses in nonobese diabetic mice.
Curr Dir Autoimmun. 2001;4:218-38. doi: 10.1159/000060535.
9
IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
J Immunol. 2001 Oct 1;167(7):4104-14. doi: 10.4049/jimmunol.167.7.4104.
10
Faulty major histocompatibility complex class I function linked to autoimmune diabetes.
Transplant Proc. 1992 Dec;24(6):2874-6.
引用本文的文献
1
HLA imputation and its application to genetic and molecular fine-mapping of the MHC region in autoimmune diseases.
Semin Immunopathol. 2022 Jan;44(1):15-28. doi: 10.1007/s00281-021-00901-9. Epub 2021 Nov 16.
2
Beta cell-specific CD8 T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes.
Nat Immunol. 2020 May;21(5):578-587. doi: 10.1038/s41590-020-0633-5. Epub 2020 Mar 30.
3
Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers.
Haematologica. 2018 Jul;103(7):1099-1109. doi: 10.3324/haematol.2016.151407. Epub 2018 Apr 19.
4
Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.
Immunology. 2016 Apr;147(4):377-88. doi: 10.1111/imm.12581. Epub 2016 Feb 8.
5
Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism.
J Hum Genet. 2015 Nov;60(11):697-702. doi: 10.1038/jhg.2015.100. Epub 2015 Aug 20.
6
Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA.
J Clin Invest. 2015 Jan;125(1):275-91. doi: 10.1172/JCI74961. Epub 2014 Dec 8.
7
Avidity-dependent programming of autoreactive T cells in T1D.
PLoS One. 2014 May 20;9(5):e98074. doi: 10.1371/journal.pone.0098074. eCollection 2014.
8
Alternative splicing and differential expression of the islet autoantigen IGRP between pancreas and thymus contributes to immunogenicity of pancreatic islets but not diabetogenicity in humans.
Diabetologia. 2013 Dec;56(12):2651-8. doi: 10.1007/s00125-013-3034-6. Epub 2013 Sep 13.
本文引用的文献
1
Weak proinsulin peptide-major histocompatibility complexes are targeted in autoimmune diabetes in mice.
Diabetes. 2008 Jul;57(7):1852-60. doi: 10.2337/db08-0068. Epub 2008 Apr 8.
2
Insulin as an autoantigen in NOD/human diabetes.
Curr Opin Immunol. 2008 Feb;20(1):111-8. doi: 10.1016/j.coi.2007.11.005.
3
Recognition of self-peptide-MHC complexes by autoimmune T-cell receptors.
Trends Biochem Sci. 2007 Nov;32(11):500-8. doi: 10.1016/j.tibs.2007.08.007. Epub 2007 Oct 22.
4
The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form.
J Immunol. 2007 May 15;178(10):6051-7. doi: 10.4049/jimmunol.178.10.6051.
5
Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.
Nature. 2005 May 12;435(7039):220-3. doi: 10.1038/nature03523.
6
Molecular interactions mediating T cell antigen recognition.
Annu Rev Immunol. 2003;21:659-84. doi: 10.1146/annurev.immunol.21.120601.141036. Epub 2001 Dec 19.
7
T cell response to preproinsulin I and II in the nonobese diabetic mouse.
J Immunol. 2002 Sep 1;169(5):2436-43. doi: 10.4049/jimmunol.169.5.2436.
8
9
HLA-DR binding analysis of peptides from islet antigens in IDDM.
Diabetes. 1998 Oct;47(10):1594-601. doi: 10.2337/diabetes.47.10.1594.
10
Biochemical characterization of the human diabetes-associated HLA-DQ8 allelic product: similarity to the major histocompatibility complex class II I-A(g)7 protein of non-obese diabetic mice.
Eur J Immunol. 1997 Oct;27(10):2478-83. doi: 10.1002/eji.1830271003.
Zotero 插件